Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo

Author： Riehle Robert D.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.20, Iss.2, 2013-02, pp. : 78-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 11, Iss. 7, 2005-03 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Pro-Apoptotic Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 293-319

Bentham Science Publishers

Access to resources Recommend Favorite

Pro-apoptotic effect of fluvastatin on human smooth muscle cells

By Buemi M.   Allegra A.   Senatore M.   Marino D.   Medici M.A.   Aloisi C.   Di Pasquale G.   Corica F.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 201-203

Elsevier

Access to resources Recommend Favorite